Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer.
Shirao K, Shimada Y, Kondo H, Saito D, Yamao T, Ono H, Yokoyama T, Fukuda H, Oka M, Watanabe Y, Ohtsu A, Boku N, Fujii T, Oda Y, Muro K, Yoshida S.
Shirao K, et al. Among authors: kondo h.
J Clin Oncol. 1997 Mar;15(3):921-7. doi: 10.1200/JCO.1997.15.3.921.
J Clin Oncol. 1997.
PMID: 9060529
Clinical Trial.